Clinical Trials Logo

Clinical Trial Details — Status: Terminated

Administrative data

NCT number NCT04796272
Other study ID # 20CH032
Secondary ID 2020-A00841-38
Status Terminated
Phase N/A
First received
Last updated
Start date April 2, 2021
Est. completion date June 30, 2022

Study information

Verified date October 2023
Source Centre Hospitalier Universitaire de Saint Etienne
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The objective of this project will be to characterise the benefits of an exercise programme adapted to each individual's abilities compared to a traditional exercise programme with the aim of reducing perceived fatigue and improving the quality of life of Patients with multiple sclerosis.


Description:

Chronic fatigue is a very common symptom reported (80%) by patients with multiple sclerosis (MS), regardless of the type of MS and level of disability. Despite the clinical importance of MS-related fatigue, pharmacological treatments remain quite ineffective in preventing or treating chronic fatigue. Recently, physical activity has proven to be an effective therapy with benefits on chronic fatigue as well as on different functions (muscular, cardiorespiratory, cognitive, etc.). Nevertheless, the effects of physical exercise may vary between MS patients, as MS is a heterogeneous disease and does not affect each individual in the same way. The objective of this project will be to characterise the benefits of an exercise programme adapted to each individual's abilities compared to a traditional exercise programme with the aim of reducing perceived fatigue and improving the quality of life of Patients with multiple sclerosis.


Recruitment information / eligibility

Status Terminated
Enrollment 30
Est. completion date June 30, 2022
Est. primary completion date February 23, 2022
Accepts healthy volunteers No
Gender All
Age group 18 Years to 70 Years
Eligibility Inclusion Criteria: - Aged 18 to 70 years old - Male or female - With relapsing-remitting multiple sclerosis (RRMS) as defined by McDonald's 2010 criteria. - Between 2 and 25 years from the onset of multiple sclerosis - With a high level of fatigue, corresponding to a score of Fatigue Severity Scale> 4 and Fatigue questionnaire > 38. - Expanded Disability Status Scale Score 5 - Testing = 4 in all leg muscles. - Ability to walk for 10 minutes without stopping (self-reported) - Affiliates or beneficiaries of a social security scheme - Having freely given their written consent after having been informed of the purpose, course of action and potential risks involved Exclusion Criteria: - Severe cerebellar spasticity or ataxia in either leg. - Abnormal range of motion of the toes and/or ankle. - Musculoskeletal injury that interferes with pedaling. - High resting heart rate (>90 beats per minute). - Blood pressure > 144/94 mmHg. - Onset of a multiple sclerosis attack within 90 days prior to the study. - Recent adjustment of any medication or drugs that may impact on fatigue, or taking stimulants for fatigue (e.g. Modafinil). - Taking of neuro-active substances that may impair cortico-spinal excitability (hypnotics, antiepileptics, psychotropic drugs, muscle relaxants) throughout the study period. - Contraindication to the application of a magnetic field - History of co-morbid disease or conditions that would compromise the subject's safety during the study. - Participation at the same time in another medical intervention study or having participated in such a study within 30 days prior to this study. - Pregnant and Nursing Women - Women of childbearing age without effective contraception - Patient unable to understand the purpose and conditions of the study, incapable of giving consent - Patient deprived of liberty or patient under guardianship

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Adapted and individualized physical training program
Physical training program adapted and individualized according to each patient in this group
traditional training program
Same training program for all patients in this group

Locations

Country Name City State
France CHU de Saint-Etienne Saint-Étienne

Sponsors (1)

Lead Sponsor Collaborator
Centre Hospitalier Universitaire de Saint Etienne

Country where clinical trial is conducted

France, 

Outcome

Type Measure Description Time frame Safety issue
Primary Chronic fatigue score assessed using the Fatigue Severity Scale (FSS) questionnaire before and after an individualized re-training program compared to a traditional re-training program in MS patients. Month 3
Secondary cardiorespiratory fitness evaluated by measuring the maximum oxygen consumption (VO2max) during an incremental exercise on a cycloergometer. Month 3
Secondary Hematological parameters red blood cell and hemoglobin levels measured by spectrophotometry. Month 3
Secondary Inflammatory parameters c-reactive protein Month 3
Secondary quality of sleep actigraphy measurements and sleep diary records Month 3
Secondary cortical activation level transcranial magnetic stimulation Month 3
Secondary cortico-spinal excitability transcranial magnetic stimulation Month 3
Secondary neuromuscular fatigue of peripheral function electrical nerve stimulation Month 3
Secondary Analysis overall quality of life : Fatigue questionnaire Fatigue questionnaire by Modified Fatigue Impact Scale (MFIS) results Month 3
Secondary Analysis overall quality of life :Quality of Life Quality of Life Questionnaire by SEP-59 results Month 3
Secondary Analysis overall quality of life :Depression Depression Questionnaire by Center for Epidemiologic Studies Depression (CES-D) results Month 3
Secondary Analysis overall quality of life : Sleep Quality Sleep Quality Questionnaire by Pittsburgh Sleep Quality Index (PSQ-I) results Month 3
Secondary Analysis overall quality of life : Physical Activity Physical Activity Questionnaire by Godin Leisure-Time Exercise Questionnaire (GLTEQ) results Month 3
See also
  Status Clinical Trial Phase
Completed NCT05528666 - Risk Perception in Multiple Sclerosis
Completed NCT03608527 - Adaptive Plasticity Following Rehabilitation in Multiple Sclerosis N/A
Recruiting NCT05532943 - Evaluate the Safety and Efficacy of Allogeneic Umbilical Cord Mesenchymal Stem Cells in Patients With Multiple Sclerosis Phase 1/Phase 2
Completed NCT02486640 - Evaluation of Potential Predictors of Adherence by Investigating a Representative Cohort of Multiple Sclerosis (MS) Patients in Germany Treated With Betaferon
Completed NCT01324232 - Safety and Efficacy of AVP-923 in the Treatment of Central Neuropathic Pain in Multiple Sclerosis Phase 2
Completed NCT04546698 - 5-HT7 Receptor Implication in Inflammatory Mechanisms in Multiple Sclerosis
Active, not recruiting NCT04380220 - Coagulation/Complement Activation and Cerebral Hypoperfusion in Relapsing-remitting Multiple Sclerosis
Completed NCT02835677 - Integrating Caregiver Support Into MS Care N/A
Completed NCT03686826 - Feasibility and Reliability of Multimodal Evoked Potentials
Recruiting NCT05964829 - Impact of the Cionic Neural Sleeve on Mobility in Multiple Sclerosis N/A
Withdrawn NCT06021561 - Orofacial Pain in Multiple Sclerosis
Completed NCT03653585 - Cortical Lesions in Patients With Multiple Sclerosis
Recruiting NCT04798651 - Pathogenicity of B and CD4 T Cell Subsets in Multiple Sclerosis N/A
Active, not recruiting NCT05054140 - Study to Evaluate Efficacy, Safety, and Tolerability of IMU-838 in Patients With Progressive Multiple Sclerosis Phase 2
Completed NCT05447143 - Effect of Home Exercise Program on Various Parameters in Patients With Multiple Sclerosis N/A
Recruiting NCT06195644 - Effect of Galvanic Vestibular Stimulation on Cortical Excitability and Hand Dexterity in Multiple Sclerosis Patients Phase 1
Completed NCT04147052 - iSLEEPms: An Internet-Delivered Intervention for Sleep Disturbance in Multiple Sclerosis N/A
Completed NCT03591809 - Combined Exercise Training in Patients With Multiple Sclerosis N/A
Completed NCT03594357 - Cognitive Functions in Patients With Multiple Sclerosis
Completed NCT02845635 - MS Mosaic: A Longitudinal Research Study on Multiple Sclerosis